首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
【24h】

Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.

机译:抗生素耐药性和适当的经验性抗生素治疗对大肠埃希菌菌血症患者预后的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Escherichia coli is the most frequent Gram-negative organism causing bacteraemia. There are few data about prognostic factors of bloodstream infections due to E. coli. In particular, the consequences of antibiotic resistance and of adequate empirical antibiotic treatment on outcome remain broadly unknown. METHODS: We conducted a retrospective cohort study of patients with E. coli bacteraemia between January 1997 and June 2005 to identify any association between antibiotic resistance, adequacy of empirical antibiotic therapy and mortality. RESULTS: Of 663 patients with E. coli bacteraemia, 36 (5.4%) died. Patients with multidrug-resistant (MDR) E. coli bacteraemia had a significantly lower frequency of correct empirical antibiotic treatment than patients with non-MDR E. coli bacteraemia [relative risk (RR) 0.53; 95% confidence interval (CI) 0.48-0.67], and also had a significantly higher mortality (RR 3.31; 95% CI 1.72-6.36). An association between the number of antibiotics to which E. coli was resistant with adequacy of empirical antibiotic (P < 0.001) and with mortality (P < 0.001) was detected. After adjustment for other significant risk factors and confounders, the inadequacy of empirical antibiotic treatment was associated with an increased mortality (adjusted OR 2.98; 95% CI 1.25-7.11). When the adequacy of empirical treatment was excluded from the model, the presence of MDR E. coli in blood cultures was also associated with the prognosis (adjusted OR 3.11; 95% CI 1.3-7.44). In multivariate analysis, other variables associated with the outcome were age, the presence of severe sepsis or shock, Charlson index score and a non-urinary origin of the bacteraemia. CONCLUSIONS: Adequacy of empirical antibiotic treatment is an independent risk factor for mortality in patients with E. coli bacteraemia. MDR E. coli bacteraemia had a worse prognosis due, at least in part, to a lower frequency of correct empirical treatment.
机译:背景:大肠杆菌是引起菌血症的最常见的革兰氏阴性菌。关于大肠杆菌引起的血流感染的预后因素的数据很少。尤其是,抗生素耐药性和适当的经验性抗生素治疗对预后的影响仍然广为人知。方法:我们对1997年1月至2005年6月的大肠杆菌菌血症患者进行了一项回顾性队列研究,以确定抗生素耐药性,经验性抗生素治疗的充分性和死亡率之间的任何关联。结果:663例大肠杆菌菌血症患者中有36例(5.4%)死亡。与非耐多药(MDR)大肠杆菌菌血症的患者相比,具有非耐多药(MDR)大肠杆菌菌血症的患者正确的经验性抗生素治疗的频率要低得多[相对风险(RR)为0.53; 95%置信区间(CI)为0.48-0.67],并且死亡率也显着较高(RR 3.31; 95%CI 1.72-6.36)。检测到大肠杆菌对经验性抗生素是否足够耐药(P <0.001)和死亡率(P <0.001)之间存在关联。在对其他重大危险因素和混杂因素进行调整之后,经验性抗生素治疗的不足会导致死亡率增加(调整后的OR 2.98; 95%CI 1.25-7.11)。当从模型中排除经验治疗的适当性时,血液培养物中MDR大肠杆菌的存在也与预后相关(校正OR 3.11; 95%CI 1.3-7.44)。在多变量分析中,与结果相关的其他变量是年龄,严重败血症或休克的存在,查尔森指数评分和菌血症的非泌尿起源。结论:经验性抗生素治疗的充分性是大肠杆菌菌血症患者死亡的独立危险因素。 MDR大肠杆菌菌血症的预后较差,至少部分原因是正确的经验治疗频率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号